Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- AEO Eligibility: Financial Solvency & Customs Compliance Requirements in 2026
- AEO Eligibility Criteria for Importers & Exporters in India 2026: Complete Guide
- DGFT Exempts Low-Value Exports from RCMC Requirement — What Exporters Need to Know
- Deemed Export Supplies Under Advance Authorisation: Benefits, Conditions & 2026 Rules
- SCOMET License Application Process on DGFT Portal: Step-by-Step 2026 Guide
- Eligible Products Under RoSCTL Scheme: Complete 2026 Guide
- CBIC Simplifies EMI Scheme Documentation: What Manufacturer-Importers Need to Know
- PIMS Registration Validity & Renewal Rules 2026: What Every Paper Importer Must Know
FeATURED ARTICLES
SARAL SIMS for Steel Imports in India – Complete Guide The Government of India has introduced SARAL SIMS (Simplified Steel…
Top Export Compliance Mistakes: DGFT Advance Authorization, EPCG & CPCB (2025 Guide) Exporting in India can feel like a legal…
Environmental Clearance CPCB: Quick Guide for Exporters If you’re an Indian exporter or manufacturer working under schemes like the Advanced…
DGFT e-BRC Rule 2025: Key Update for Advance Authorization & EPCG Holders The Directorate General of Foreign Trade (DGFT) has…


